CS logo
small CS logo
Digestive Disease Institute, Virginia Mason Medical Center

Seattle, Washington, United States
Gastroenterologist in Seattle, Washington
1100 Ninth Ave Buck Pavilion, Level 3, Seattle, WA 98101

About Digestive Disease Institute, Virginia Mason Medical Center


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Digestive Disease Institute, Virginia Mason Medical Center


During the past decade, Digestive Disease Institute, Virginia Mason Medical Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Digestive Disease Institute, Virginia Mason Medical Center" #1 sponsor was "Gilead Sciences" with 4 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Takeda" with 1 trials sponsored, "Tigenix S.A.U." with 1 trials sponsored and "Ventrus Biosciences, Inc" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

Clinical Trials Conditions at Digestive Disease Institute, Virginia Mason Medical Center


According to Clinical.Site data, the most researched conditions in "Digestive Disease Institute, Virginia Mason Medical Center" are "Crohn Disease" (2 trials), "Crohn's Disease" (2 trials), "Hepatitis C, Chronic" (2 trials), "Chronic Anal Fissures" (1 trials) and "Chronic Hepatitis C Infection" (1 trials). Many other conditions were trialed in "Digestive Disease Institute, Virginia Mason Medical Center" in a lesser frequency.

Clinical Trials Intervention Types at Digestive Disease Institute, Virginia Mason Medical Center


Most popular intervention types in "Digestive Disease Institute, Virginia Mason Medical Center" are "Drug" (8 trials), "Biological" (4 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Copegus®" (2 trials), "Etrolizumab" (2 trials), "Pegasys®" (2 trials) and "Cx601" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Digestive Disease Institute, Virginia Mason Medical Center


The vast majority of trials in "Digestive Disease Institute, Virginia Mason Medical Center" are 9 trials for "All" genders.

Clinical Trials Status at Digestive Disease Institute, Virginia Mason Medical Center


Currently, there are NaN active trials in "Digestive Disease Institute, Virginia Mason Medical Center". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Digestive Disease Institute, Virginia Mason Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Digestive Disease Institute, Virginia Mason Medical Center, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".